The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago, underscoring the disease's resilience.
This disease is promoted by a hypoxic niche that drives several aspects of tumor growth and resistance to therapy, and understanding the mechanisms behind its growth can lead to new therapies.
Collection
[
|
...
]